Trademark: 77238363
Word
MENISCOCELECT
Status
Dead
Status Code
710
Status Date
Friday, March 11, 2016
Serial Number
77238363
Registration Number
3662384
Registration Date
Tuesday, August 4, 2009
Mark Type
5000
Filing Date
Wednesday, July 25, 2007
Published for Opposition
Tuesday, May 19, 2009
Cancellation Date
Friday, March 11, 2016

Trademark Owner History
TIGENIX N.V. - Original Registrant

Classifications
1 Enzymes for scientific research and development in the medical field; antibodies for medical laboratory use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for scientific or research use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for research/scientific use
5 Antibodies for medical diagnostic use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; pharmaceutical, veterinary or medical preparations for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells; nutritious media and growth substrates for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical preparations, namely, polymer preparations and cell matrices of any type of origin for expansion, selection, medical quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; test products for medical use, for the purpose of the control of expansion, selection, and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, chondrocytes, chondrocyte progenitors, chondrocyte precursors and stem cells with chondrogenic properties; hormones for the promoting of the growth of cells called growth factors for medical use; veterinary or medical kits for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits primarily composed of growth and differentiating promoting polypeptides; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for medical or veterinary use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants for medical/diagnostic use; implementation kits consisting primarily of live cartilage forming cells
10 Veterinary or medical devices and instruments for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits comprised of temperature probes and injectors, stitching or gluing material for covering implantation devices for human in vivo, cartilage forming cells; medical devices and instrument kits, namely, biopsy instruments, implantation kits including medical syringes, tongs and pliers; quality control kits consisting primarily of DNA chips for medical use including expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants
42 Scientific research, development and study related to expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; quality control for others as related in human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; custom design, development and performance of biochemical assays for the purpose of quality control of expanded or implanted human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; scientific research, development and study related to the use of polymer membranes or cell matrices of any type of origin for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants
44 Pharmaceutical, veterinary or medical services, namely, medical and pharmaceutical consultation and veterinary services
Color is not claimed as a feature of the mark.

Trademark Events
Mar 11, 2016
Cancelled Sec. 8 (6-Yr)
Jan 23, 2014
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 23, 2014
Teas Change Of Owner Address Received
Aug 4, 2009
Registered-Principal Register
May 19, 2009
Published For Opposition
Apr 29, 2009
Notice Of Publication
Apr 13, 2009
Law Office Publication Review Completed
Apr 9, 2009
Approved For Pub - Principal Register
Apr 9, 2009
Teas/Email Correspondence Entered
Apr 9, 2009
Correspondence Received In Law Office
Apr 9, 2009
Teas Response To Office Action Received
Mar 5, 2009
Notification Of Priority Action E-Mailed
Mar 5, 2009
Priority Action E-Mailed
Mar 5, 2009
Priority Action Written
Feb 9, 2009
Previous Allowance Count Withdrawn
Jan 16, 2009
Withdrawn From Pub - Og Review Query
Jan 8, 2009
Law Office Publication Review Completed
Dec 20, 2008
Approved For Pub - Principal Register
Dec 19, 2008
Teas/Email Correspondence Entered
Dec 19, 2008
Correspondence Received In Law Office
Dec 19, 2008
Teas Response To Office Action Received
Jun 21, 2008
Notification Of Non-Final Action E-Mailed
Jun 21, 2008
Non-Final Action E-Mailed
Jun 21, 2008
Non-Final Action Written
Jun 13, 2008
Previous Allowance Count Withdrawn
Jun 2, 2008
Withdrawn From Pub - Og Review Query
May 22, 2008
Law Office Publication Review Completed
May 22, 2008
Approved For Pub - Principal Register
May 1, 2008
Teas/Email Correspondence Entered
May 1, 2008
Correspondence Received In Law Office
Apr 30, 2008
Teas Response To Office Action Received
Oct 31, 2007
Notification Of Non-Final Action E-Mailed
Oct 31, 2007
Non-Final Action E-Mailed
Oct 31, 2007
Non-Final Action Written
Oct 30, 2007
Assigned To Examiner
Oct 25, 2007
Applicant Amendment Prior To Examination - Entered
Oct 18, 2007
Assigned To Lie
Sep 13, 2007
Paper Received
Jul 30, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24